For instance, serum prostate-specific antigen (PSA) is the most reliable and widely used clinical biomarker for diagnosing prostate cancer, and successful therapy for prostate cancer depends heavily on the detection of biomarkers [24,25]. This evidence concerns the gene KLK3 and prostate cancer.